Medicare Compliance & Reimbursement - 2014 Issue 9
ICD-10: 174.8 Yields More Specific Crosswalks
Subscribe or sign in to view the full article.
Article Overview
This article reviews an ICD-9 to ICD-10 crosswalk for breast cancer reporting and explains the broader shift in how breast neoplasm locations are represented. It is useful for coders, billing staff, and clinical documentation reviewers who need to understand the scope of the ICD-10 replacement categories, including laterality, overlapping sites, and related breast cancer coding distinctions.
Why This Topic Matters
The article helps readers understand why legacy breast cancer codes no longer map to a single ICD-10 equivalent and how documentation specificity affects code selection at a high level. It is especially relevant for teams reviewing diagnosis reporting changes tied to the ICD-10 transition.
Article Sections
-
Crosswalk overview for breast cancer reporting
Introduces the ICD-9 to ICD-10 transition for breast cancer site reporting and the general move toward more specific replacement categories.
-
Laterality and overlapping-site distinctions
Discusses how breast cancer location is represented in ICD-10, including broader distinctions tied to site specificity and laterality.
-
Vague site descriptors and unspecified options
Explains the article’s discussion of broad breast location descriptors and the availability of unspecified reporting when documentation is not precise enough.
-
Ectopic tissue and male breast cancer notes
Covers the article’s additional notes on ectopic tissue references and the inclusion of male breast cancer within the ICD-10 breast neoplasm family.
-
Example
Provides a brief breast cancer reporting example illustrating the article’s broader comparison between ICD-9 and ICD-10 terminology.
What You Will Learn
- How an older breast cancer diagnosis code relates to ICD-10 replacement categories
- What broad documentation elements affect breast site reporting
- How ICD-10 distinguishes breast neoplasm reporting at a high level
- What additional breast cancer coding topics are discussed alongside the crosswalk
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Clinical documentation improvement teams
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com